Riudavets, M, Bosch-Barrera, J, Cabezon-Gutierrez, L, Tain, PD, Hernandez, A, Alonso, M, Blanco, R, Galvez, E, Insa, A, Mielgo, X, Moran, T, Ponce, S, Roa, D, Sanchez, JM, Majem, M. Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma. Clinical & Translational Oncology. 2021; 23(12)DOI:10.1007/s12094-021-02661-2. PMID:34292495. IF:3.340(Q3/7D).

Martinez-Trufero, J, Jurado, JC, Gomez-Mateo, MC, Bernabeu, D, Floria, LJ, Lavernia, J, Sebio, A, del Muro, XG, Alvarez, R, Correa, R, Hernandez-Leon, CN, Marquina, G, Hindi, N, Redondo, A, Martinez, V, Asencio, JM, Mata, C, Morales, CMV, Martin-Broto, J. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part I. CANCER TREATMENT REVIEWS. 2021; 99DOI:10.1016/j.ctrv.2021.102259. PMID:34311246. IF:13.608(Q1/1D).

Martinez-Trufero, J, Jurado, JC, Hernandez-Leon, CN, Correa, R, Asencio, JM, Bernabeu, D, Alvarez, R, Hindi, N, Mata, C, Marquina, G, Martinez, V, Redondo, A, Floria, LJ, Gomez-Mateo, MC, Lavernia, J, Sebio, A, del Muro, XG, Martin-Broto, J, Valverde-Morales, C. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II. CANCER TREATMENT REVIEWS. 2021; 99DOI:10.1016/j.ctrv.2021.102260. PMID:34340159. IF:13.608(Q1/1D).

Puente, J, Pinto, A, Mendez-Vidal, MJ, del Muro, XG, Maroto, P, Vazquez, S, Luque-Caro, R, Anido, U, Strunz-McKendry, T, Upadhyay, A, Montes, J, Nuñez, AO, Portela, JG, Castellano, D. Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain. Clinical & Translational Oncology. 2025; 27(5)DOI:10.1007/s12094-024-03734-8. PMID:39365365. IF:2.500(Q3/6D).